Literature DB >> 32282077

The Chicago Consensus on peritoneal surface malignancies: Management of peritoneal mesothelioma.

.   

Abstract

The Chicago Consensus Working Group provides multidisciplinary recommendations for the management of peritoneal mesothelioma. These guidelines are developed with input from leading experts, including surgical oncologists, medical oncologists, pathologists, radiologists, palliative care physicians, and pharmacists. These guidelines recognize and address the emerging need for increased awareness of the appropriate management of peritoneal surface disease. They are not intended to replace the quest for higher levels of evidence.
© 2020 by the American Cancer Society and Society of Surgical Oncology.

Entities:  

Keywords:  consensus; mesothelioma; neoplasm metastasis; peritoneal neoplasms

Mesh:

Year:  2020        PMID: 32282077     DOI: 10.1002/cncr.32870

Source DB:  PubMed          Journal:  Cancer        ISSN: 0008-543X            Impact factor:   6.860


  5 in total

1.  Comprehensive Treatment Algorithms of the Swiss Peritoneal Cancer Group for Peritoneal Cancer of Gastrointestinal Origin.

Authors:  Michel Adamina; Maxime Warlaumont; Martin D Berger; Silvio Däster; Raphaël Delaloye; Antonia Digklia; Beat Gloor; Ralph Fritsch; Dieter Koeberle; Thibaud Koessler; Kuno Lehmann; Phaedra Müller; Ralph Peterli; Frédéric Ris; Thomas Steffen; Christian Stefan Weisshaupt; Martin Hübner
Journal:  Cancers (Basel)       Date:  2022-09-01       Impact factor: 6.575

2.  Malignant Peritoneal Mesothelioma: A Challenging Case for Palliative Care.

Authors:  Carolina Vidal; Inês Romero; Isabel Neto
Journal:  Cureus       Date:  2022-08-01

3.  Safe performance of cytoreductive surgery and hyperthermic intraperitoneal chemotherapy in patients with HIV infection.

Authors:  Anna Coghill; Julian Sanchez; Sweta Sinha; Jennifer B Permuth; Danielle Laskowitz; Benjamin D Powers; Sean P Dineen
Journal:  Cancer Rep (Hoboken)       Date:  2022-07-22

Review 4.  Surgical Management of Neuroendocrine Tumor Liver Metastases.

Authors:  Catherine G Tran; Scott K Sherman; Chandrikha Chandrasekharan; James R Howe
Journal:  Surg Oncol Clin N Am       Date:  2020-10-20       Impact factor: 3.495

5.  Efficacy, Safety, and Biomarker Analysis of Combined PD-L1 (Atezolizumab) and VEGF (Bevacizumab) Blockade in Advanced Malignant Peritoneal Mesothelioma.

Authors:  Gauri R Varadhachary; Daniel M Halperin; Kanwal Raghav; Suyu Liu; Michael J Overman; Anneleis F Willett; Mark Knafl; Szu-Chin Fu; Anais Malpica; Seema Prasad; Richard E Royal; Christopher P Scally; Paul F Mansfield; Ignacio I Wistuba; Andrew P Futreal; Dipen M Maru; Luisa M Solis Soto; Edwin R Parra Cuentas; Honglei Chen; Pamela Villalobos; Anuj Verma; Armeen Mahvash; Patrick Hwu; Patricia Cortazar; Edward McKenna; Cindy Yun; Shannon Dervin; Katja Schulze; Walter C Darbonne; Ajaykumar C Morani; Scott Kopetz; Keith F Fournier; Scott E Woodman; James C Yao
Journal:  Cancer Discov       Date:  2021-07-14       Impact factor: 39.397

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.